QA: Paratek Pharmaceuticals Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2016_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 142,417,000
1 IntangibleAssetsNetIncludingGoodwill 2,178,000
2 PropertyPlantAndEquipmentNet 779,000
3 remainder_Assets 544,000
4 LiabilitiesCurrent 20,502,000
5 LiabilitiesNoncurrent 23,176,000
6 remainder_Liabilities 1,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,502,742
9 ResearchAndDevelopmentExpense 34,262,657
10 remainder_Expenses -449,448
11 remainder_Revenues 0
12 remainder_NetIncome -4,339,563
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 145,918,000
1 Liabilities 44,678,000
2 Expenses 47,315,951
3 Revenues 0
4 StockholdersEquity 101,240,000
5 NetIncome -51,655,514
6 ComprehensiveNetIncome -51,655,514
7 BaseVar 121,125,757
8 EconomicCapitalRatiobeforeLimitedLiability 1.77
9 EconomicCapitalRatio 2.87

Edgar->Model Mapping

Feature Distribution

Change over Time